Introducing nymble engage: Building the Bridge Between Compliance and Innovation in Patient Support

Over the past year and a half, we’ve worked closely with partners across the life sciences industry - listening, learning, and designing solutions to better support patients throughout their obesity treatment journey.

The message has been clear: There is strong enthusiasm for the promise of modern technology in Patient Support Programs (PSPs), but also a deep caution about moving too quickly.

Across the industry, teams recognize the operational and strategic imperative to deploy scalable, high-quality support and adherence solutions. Yet the practical barriers to implementing patient-facing generative AI remain significant. Concerns around adverse event reporting, internal AI governance, content management and approval have added new layers of complexity to an already lengthy procurement and compliance process. While these can all be surmounted, they create delays to deployment.

From listening to action

At nymble, we wanted to solve this problem. What if there were a solution that met the immediate operational and regulatory realities of PSPs, while laying the groundwork for a safer, effective pathway to adopt patient-facing generative AI tools?

nymble engage is that solution.

It’s a first-in-class behavioural automation and engagement platform, designed specifically for pharmaceutical PSPs, that provides a structured pathway for the safe and gradual adoption of generative AI capabilities. Built on the same evidence-based foundation and behavioural science that power nymble’s core platform, nymble engage delivers scalable patient engagement, measurable adherence impact, and meaningful operational efficiency - without the present-day regulatory friction that often accompanies generative AI tools.

Purpose-built for today’s PSP needs

nymble engage is optimized for deployment in real-world pharma environments. It provides:

• Compliant, automated behavioural support that can be deployed rapidly and scaled seamlessly across diverse patient populations and markets

• Insight collection on patient adherence and engagement - without gathering adverse event data

• Multi-channel delivery via popular consumer messaging formats (SMS, iMessage, WhatsApp, Android RCS) and optimized for delivery via API, that meets patients where they are

• Integrated delivery of official PSP content, such as manufacturer-produced administration videos or educational materials, ensuring a consistent, evidence-aligned patient experience.

Opportunity to custom build optional modules to unlock operational efficiency and improved patient experience such as for special access forms and clinical trial recruitment  - enabling deeper partnership opportunities.

The result is a platform that’s both pragmatic and progressive: capable of driving immediate impact while serving as a safe foundation for future innovation.

The adoption ladder for generative AI

nymble engage also marks an important milestone in how we think about the evolution of digital patient support. It introduces a continuum of intelligence across our product offerings - an adoption ladder that allows organizations to selectively and safely deploy features that leverage generative AI, on their own terms.

For example, a decision could be made to enable AI-driven educational conversations restricted to the science of obesity, while keeping discussions around side effect management fully scripted and reviewed. At a later date, tooling could be enabled to allow more free-form conversation on broader topics such as side effects, nutrition and physical activity.

This flexibility transforms nymble into a configurable sandbox - a place where partners can build and evolve their patient support infrastructure with confidence, precision, and control.

Why it matters

For patients, long-term treatment success isn’t driven by the amount of information they receive. It’s driven by understanding, convenience, and consistency.

For our partners, success means being able to deliver that experience safely, at scale, and with measurable outcomes.

nymble engage was built to make that possible today, while preparing organizations to embrace tomorrow’s technology responsibly.

---

Interested in learning more?

We’re excited to share nymble engage with the PSP and life sciences community, as well as others seeking a streamlined patient support platform for obesity.

📍 Meet us in person at the Patient Support Summit in Toronto on November 4–5th, or at Obesity Week in Atlanta November 4-7th.

📧 Or reach out to us directly at hello@nymble.health to explore how nymble engage can fit into your organization’s support ecosystem.